MCRB
#4176
Seres Therapeutics, Inc. - Common Stock
7.1 6 USD
-0.12%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-12.04%
Monthly Change
+10.66%
6 month change
-13.00%
Year Change
-13.00%
Previous Close
8.1 4
Open
7.2 6
Low
7.1 4
High
7.3 6
Volume
80
Financials
- Market Capitalization 68.64 M
- Employee 66
- Founded 2010
- CEO Eric Shaff
- Website www.serestherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG0099X6859
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.25
Price to sales ratio
167.28
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4166 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.17 USD | 0.00% | +3.54% | +0.86% | -2.50% | 72.45 M USD | ||
| 4175 |  MNOV MediciNova, Inc. - Common Stock | 1.43 USD | -1.38% | -5.30% | +10.85% | +13.49% | 70.39 M USD | ||
| 4186 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.41 USD | -6.62% | -13.50% | -11.88% | -30.20% | 65.08 M USD | ||
| 4188 |  ANVS Annovis Bio, Inc. Common Stock | 1.97 USD | +2.07% | +2.60% | +7.07% | -24.52% | 68.25 M USD |
Frequently asked questions about Seres Therapeutics, Inc. - Common Stock
What is the Seres Therapeutics, Inc. - Common Stock stock price today?
The current price of Seres Therapeutics, Inc. - Common Stock (MCRB) is 7.16. Over the past 24 hours, the stock has changed by -12.04%. Follow the MCRB chart for real-time price dynamics.
What is the stock ticker of Seres Therapeutics, Inc. - Common Stock?
Seres Therapeutics, Inc. - Common Stock trades under the ticker MCRB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Seres Therapeutics, Inc. - Common Stock stock going up?
MCRB has changed by -8.91% over the last week, +10.66% over the last month, and -13.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Seres Therapeutics, Inc. - Common Stock net income for the last quarter?
Seres Therapeutics, Inc. - Common Stock reported net income of -19.91 M for the last quarter. The previous quarter showed -15.34 M, which means net income changed by -29.85%.
How many employees does Seres Therapeutics, Inc. - Common Stock have?
As of the latest available data, Seres Therapeutics, Inc. - Common Stock has 66 employees. Workforce size can provide additional context about the company's scale and operations.
What is Seres Therapeutics, Inc. - Common Stock EBITDA?
Seres Therapeutics, Inc. - Common Stock EBITDA is -20.13 M, and its EBITDA margin is -5 621.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Seres Therapeutics, Inc. - Common Stock stock?
You can buy Seres Therapeutics, Inc. - Common Stock (MCRB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Seres Therapeutics, Inc. - Common Stock stock?
Investing in Seres Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MCRB chart and related analysis on metatrader.com as part of your research.